Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial.
about
Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Assessing the Efficacy and Saf ...... I Randomized Controlled Trial.
@en
Assessing the Efficacy and Saf ...... I Randomized Controlled Trial.
@nl
type
label
Assessing the Efficacy and Saf ...... I Randomized Controlled Trial.
@en
Assessing the Efficacy and Saf ...... I Randomized Controlled Trial.
@nl
prefLabel
Assessing the Efficacy and Saf ...... I Randomized Controlled Trial.
@en
Assessing the Efficacy and Saf ...... I Randomized Controlled Trial.
@nl
P2093
P2860
P50
P356
P1476
Assessing the Efficacy and Saf ...... II Randomized Controlled Trial
@en
P2093
Alexandra J Sinclair
Caroline Rick
James L Mitchell
Keira Annie Markey
Natalie Ives
Peter Nightingale
Rebecca Woolley
Ryan Ottridge
P2860
P356
10.2196/RESPROT.7806
P50
P577
2017-09-18T00:00:00Z